Archive for category: Melanoma

Thoughts on combination therapies

0 / May 31, 2014 9:27 am

orning it’s Day 1 of ASCO 2014 and it’s already a mad house. The combo Phase 1 study of ipilimumab, dabrafenib (BRAF inhib) and trametinib (MEK inhib) has been presented. Interestingly, the doublet combination (Ipi plus Dab) did not […]

ASCO preview 2014: TheMelanomaCenter edition

0 / May 30, 2014 8:20 pm

17;s once again time for ASCO, or the American Society of Clinical Oncology, where more than 25,000 oncology doctors as well as countless pharma, biotech, genomic testing, and assorted media types converge on downtown Chicago and the McCormick Convention Center […]

Review of BRAF/MEK Combo NEJM data

0 / October 3, 2012 4:32 pm

eat results from multiple clinical trials treating advanced melanoma keep coming, as the NEJM publication from this GSK (Glaxo SmithKline)-sponsored trial recently affirmed. This trial was a Phase I-II trial of combination therapy for advanced melanoma harboring a v600 […]

ASCO 2012 Melanoma Posters

0 / June 3, 2012 9:52 pm

ost will cover both the “discussed” posters, generally felt to be more important by ASCO organizers, and the “general” posters. Instead of going through all the posters, I have selected the ones I found most interesting: A phase II single […]

Anti-PD-1 Therapy

0 / June 2, 2012 5:14 am

CO press releases have begun; first up to the plate is BMS and their anti-PD-1 antibody. Similar to ipilimumab, this drug works through immune system checkpoint modulation.In other words, it works by releasing the natural inhibition of our immune […]

ASCO 2012 schedule

0 / June 2, 2012 4:35 am

s the schedule of melanoma-related events for ASCO this year. It is possible that I have missed some Phase I presentations with melanoma patients included. Friday June 1: No sessions Saturday, June 2: 8 am “New Options, New Questions: […]

ASCO 2012 preview

ASCO 2012 preview

0 / June 1, 2012 8:07 pm

ear’s ASCO (American Society of Clinical Oncology) meeting will once again be held in Chicago IL at the mammoth McCormick Place Convention Center. The overall theme for this year’s meeting is, “Collaborating to Conquer Cancer.” This is an interesting […]

Today’s Thought: What matters in treatment choices?

24 / December 10, 2011 12:32 am

y melanoma meetings, the issue of treatment of metastatic disease with Interleukin-2 comes up. The room quickly divides into two sides, the true-believers and not-in-my-cancer-centers. The two groups both mean well and are both completely versed in the pros […]

New Feature! “Melanoma Thought of the Day”

0 / December 10, 2011 12:08 am has been a little quiet lately, as the Senior Editor struggles with increased workload, college application assistance, and other obligations that cut down on available time, including readying several books for publication in the near future. However, Dr. Whitman […]

California bans sunbed use by minors

0 / October 10, 2011 12:55 am

mes, California gets it right and is a trendsetter we all could and should respect and emulate. On Sunday, October 9, 2011, Cslifornia became the first state to ban Sunbed use by minors (under age 18). Previously, California like other […]

Shopping Cart (0 Items)
Your cart is empty!

Subtotal: $0.00
Total: $0.00